Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVERTAS: Switch to Dovato vs Triumeq in HIV
NCT04904406Phase 4Completed
- Start
- Oct 2020
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of dolutegravir + lamivudine in human immunodeficiency virus infection (HIV). Started Oct 2020; status: completed.
02
Drugs
dolutegravir + lamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04904406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04904406.